Clinical Trial Update: Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan, cisplatin, and radiation therapy with or without celecoxib for Stage II–IV esophageal cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Celecoxib (Celecoxib)
• Irinotecan (Irinotecan)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED